Steps towards implementation of protocolized dose reduction of adalimumab, etanercept and ustekinumab for psoriasis in daily practice.
Lara S van der SchootJ J JanssenM T BastiaensA de Boer-BrandC Christiaansen-SmitD N H EnomotoR HovinghR A TupkerM M B SeygerL M VerhoefJ M P A van den ReekE M G J de JongPublished in: The Journal of dermatological treatment (2023)
Additional staff for support, extra time during consultations, education on DR for HCPs and patients, and effective tools such as a feasible protocol can lead to more patients on biologic DR.